Cargando…
DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) patients are highly angiogenic and treated by targeted therapies against VEGFA/VEGFR signaling pathway. However, tumors with such targeted therapies remain a significant clinic challenge. Understanding the underlying mechanism against angiogenesis is highly de...
Autores principales: | Zhu, Yumeng, Liu, Xiaojun, Wang, Yang, Pan, Yongbo, Han, Xiaoqi, Peng, Bo, Zhang, Xu, Niu, Shaoxi, Wang, He, Ye, Qinong, Gu, Yinmin, Gao, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106801/ https://www.ncbi.nlm.nih.gov/pubmed/35562342 http://dx.doi.org/10.1038/s41419-022-04898-3 |
Ejemplares similares
-
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
Analysis and verification of N(6)-methyladenosine-modified genes as novel biomarkers for clear cell renal cell carcinoma
por: Yang, Zhenyu, et al.
Publicado: (2021) -
Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer
por: Wang, Guannan, et al.
Publicado: (2021) -
Smurf1 regulation of DAB2IP controls cell proliferation and migration
por: Li, Xiaoning, et al.
Publicado: (2016) -
Xenopus Dab2 is required for embryonic angiogenesis
por: Cheong, Seong-Moon, et al.
Publicado: (2006)